Research is underway into patenting treatments for the Sars virus. But patent systems are not the same everywhere, especially where living organisms are concerned. Researchers need to be aware of the differences, warns Aaradhana Sadasivam
Unlock this article.
The content you are trying to view is exclusive to our subscribers.